SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (1237)12/2/1999 1:33:00 PM
From: Lighthouse  Respond to of 3202
 
It is a good thing we do not own Curagen. Then we would have made some money. 8-)

However, CRGN's SNP work is analogous to Incyte's LifeExpress database efforts. Correct?



To: LLCF who wrote (1237)12/2/1999 3:02:00 PM
From: hoyasaxa  Read Replies (1) | Respond to of 3202
 
Incyte versus Celera: Is the battle over before its begun ? (eom)



To: LLCF who wrote (1237)12/2/1999 3:55:00 PM
From: sharecropper2  Read Replies (1) | Respond to of 3202
 
Has anyone seen the news release today that Incyte have filed patent applications for 50,000 genes ( in other words nearly all the genes with medical potential) ??


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News